Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

WX

(WX)

Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:WX
FechaHoraFuenteTítuloSímboloCompañía
04/03/201910:00Business WireIMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against WuXi PharmaTech (Caym...NYSE:WX
01/03/201917:32Business WireIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against WuXi PharmaTech (Cayman)...NYSE:WX
31/08/201716:27Edgar (US Regulatory)Confidential Treatment Order (ct Order)NYSE:WX
22/09/201607:00PR Newswire (US)WuXi Biologics Completes Construction of Asia's Largest Perfusion Biologics Manufacturing Facility Using Disposable Bioreacto...NYSE:WX
27/04/201603:18PR Newswire (US)LabNetwork Forges eCommerce Alliances with Leading Chemical ProvidersNYSE:WX
10/02/201609:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:WX
11/01/201609:37Edgar (US Regulatory)Schedule 13g
(sc 13g/a)
NYSE:WX
16/12/201501:40PR Newswire (US)WuXi and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in ChinaNYSE:WX
13/12/201517:00PR Newswire (US)WuXi PharmaTech Presents 2015 Life Science and Chemistry AwardsNYSE:WX
11/12/201513:10Edgar (US Regulatory)(25-NSE)NYSE:WX
10/12/201516:14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:WX
10/12/201516:02Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:WX
10/12/201515:49Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NYSE:WX
10/12/201515:45PR Newswire (US)WuXi PharmaTech (Cayman) Inc. Announces Completion of Going Private TransactionNYSE:WX
07/12/201518:00GlobeNewswire Inc.WuXi PharmaTech and PRA Health Sciences Restructure Relationship in ChinaNYSE:WX
07/12/201507:00PR Newswire (US)Dr. Ge Li Receives Executive of the Year Award from SCRIPNYSE:WX
01/12/201508:50Dow Jones NewsChina's Qihoo 360 Moving Closer to $9 Billion BuyoutNYSE:WX
24/11/201521:00PR Newswire (US)WuXi PharmaTech Announces Shareholders' Approval of Merger AgreementNYSE:WX
12/11/201503:37PR Newswire (US)Genomics England Contracts with WuXi NextCODE as Clinical Interpretation Partner in both Rare Disease and CancerNYSE:WX
11/11/201511:01PR Newswire (US)ISS and Glass Lewis Recommend that WuXi PharmaTech Shareholders Vote "FOR" the Proposed Going-Private TransactionNYSE:WX
10/11/201515:30PR Newswire (US)WuXi PharmaTech and Lilly Announce Strategic Collaboration to Develop Novel Therapeutic in ChinaNYSE:WX
09/11/201507:00GlobeNewswire Inc.Lion Biotechnologies Announces Agreement With WuXi AppTec to Increase TIL Manufacturing CapacityNYSE:WX
05/11/201514:17PR Newswire (US)WuXi PharmaTech Congratulates Novira TherapeuticsNYSE:WX
03/11/201515:05PR Newswire (US)WuXi PharmaTech Announces Third-Quarter 2015 ResultsNYSE:WX
03/11/201505:00PR Newswire (US)Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome ProjectNYSE:WX
29/10/201521:00PR Newswire (US)Gilead Sciences and WuXi PharmaTech Announce Collaboration for a Dedicated Analytical and Stability Testing FacilityNYSE:WX
20/10/201509:00PR Newswire (US)WuXi PharmaTech (Cayman) Inc. Announces Extraordinary General Meeting of ShareholdersNYSE:WX
19/10/201507:00PR Newswire (US)Dr. Peter Schultz, CEO of The Scripps Research Institute, Visits WuXi AppTec Headquarters in ShanghaiNYSE:WX
16/10/201507:00PR Newswire (US)WuXi PharmaTech Receives 2015 Asian CRO Company of the Year Award from Frost & SullivanNYSE:WX
13/10/201507:00PR Newswire (US)WuXi PharmaTech Launches Mobile OncoWuXi, the World's First App for Accessing Oncology ModelsNYSE:WX
 Showing the most relevant articles for your search:NYSE:WX

Su Consulta Reciente